Ειδήσεις: 20/20 BIOLABS | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

25/03 07:26 defenseworld.net

Critical Comparison: Applied Dna Sciences (NASDAQ:BNBX) vs. 20/20 Biolabs (NASDAQ:AIDX)

20/20 Biolabs Applied DNA Sciences small‑cap revenue comparison earnings institutional ownership

19/03 07:50 defenseworld.net

Reviewing 20/20 Biolabs (NASDAQ:AIDX) and Applied Dna Sciences (NASDAQ:BNBX)

biotech small‑cap 20/20 Biolabs Applied DNA Sciences profitability analyst ratings

16/03 07:58 defenseworld.net

Applied Dna Sciences (NASDAQ:BNBX) vs. 20/20 Biolabs (NASDAQ:AIDX) Financial Survey

small‑cap biotech Applied DNA Sciences 20/20 Biolabs earnings valuation

15/03 07:07 defenseworld.net

20/20 Biolabs (NASDAQ:AIDX) and Applied Dna Sciences (NASDAQ:BNBX) Financial Survey

20/20 Biolabs Applied DNA Sciences small‑cap profitability valuation institutional ownership

15/03 07:07 defenseworld.net

20/20 Biolabs (NASDAQ:AIDX) and Applied Dna Sciences (NASDAQ:BNBX) Financial Survey

20/20 Biolabs Applied DNA Sciences small‑cap profitability valuation institutional ownership

Loading...